Applied Clinical Trials-11-01-2020

Similar to a world-class symphony, a curated site start-up model can accentuate its individual components and lead to swift starts for clinical trials.

Sujay Jadhav, global vice president, study start-up, Oracle Health Sciences, spoke with ACT on how study start-up has been impacted by the pandemic and what its future holds beyond COVID.

With a major wave of post-COVID trial starts on the horizon, the industry’s need to accelerate clinical research through study start-up is intensifying.

COVID-19 pandemic shifts traditional process for medicine development in Europe.

FDA’s Vaccines and Related Biological Products Advisory Committee addresses issues related to testing and approval of potential COVID vaccines.

The FDA hints that their increased speed in issuing guidances during the pandemic could become the new norm.

Click the title above for a link to open the Applied Clinical Trials November 2020 issue in an interactive PDF format.

A compilation of recent notable news developments that pertain to the clinical trials industry.

Bayesian methods bring flexibility and speed to clinical trial design and analysis, and with increased access to the necessary computational power, are transforming today’s clinical research.

Declarations made by Beate Wieseler don't align with those of many regulators and HTA bodies in Europe and will prove tough to transform.